These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4868527)

  • 1. Comparative studies of ampicillin, cephalothin and a new cephalosporin derivative, cephaloglycin.
    Kunin CM; Brandt D
    Am J Med Sci; 1968 Mar; 255():196-201. PubMed ID: 4868527
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic.
    Levison ME; Johnson WD; Thornhill TS; Kaye D
    JAMA; 1969 Sep; 209(9):1331-6. PubMed ID: 4895869
    [No Abstract]   [Full Text] [Related]  

  • 3. Bactericidal activity of the ampicillin-kanamycin combination against Escherichia coli, Enterobacter-Klebsiella and Proteus.
    Bulger RJ; Roosen-Runge U
    Am J Med Sci; 1969 Jul; 258(1):7-13. PubMed ID: 4894496
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacteriological and clinical activity of the ampicillin-gentamicin and cephalothin-gentamicin combinations.
    Klastersky J; Cappel R; Swings G; Vandenborre L
    Am J Med Sci; 1971 Nov; 262(5):283-90. PubMed ID: 4946832
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental evaluation of the new cephalosporin antibiotic cephacetrile].
    Kradolfer F; Ahrens T; Gelzer J; Vischer W; Zimmermann W
    Arzneimittelforschung; 1974 Sep; 24(9b):1446-51. PubMed ID: 4154769
    [No Abstract]   [Full Text] [Related]  

  • 6. Cephaloridine: antimicrobial activity and pharmacologic behavior.
    Kaplan K; Reisberg BE; Weinstein L
    Am J Med Sci; 1967 Jun; 253(6):667-74. PubMed ID: 4381751
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the use of cephalexin in children].
    Marget W; Daschner F
    Arzneimittelforschung; 1969 Dec; 19(12):1956-8. PubMed ID: 4985337
    [No Abstract]   [Full Text] [Related]  

  • 8. Laboratory determination of antibiotic susceptibility to ampicillin and cephalothin.
    Sherris JC; Rashad AL; Lighthart GA
    Ann N Y Acad Sci; 1967 Sep; 145(2):248-67. PubMed ID: 4935172
    [No Abstract]   [Full Text] [Related]  

  • 9. A semiautomated microcalorimetric method of antibiotic sensitivity testing.
    Binford JS; Binford LF; Adler P
    Am J Clin Pathol; 1973 Jan; 59(1):86-94. PubMed ID: 4631819
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial studies in vitro with cephacetrile, a new cephalosporin derivative.
    Knüsel F; Konopka EA; Gelzer J; Rosselet A
    Arzneimittelforschung; 1974 Sep; 24(9b):1451-5. PubMed ID: 4215433
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and laboratory evaluation of cefanone, a new cephalosporin antibiotic.
    Noriega ER; Rubinstein E; Simberkoff MS; Rahal JJ
    Am J Med Sci; 1974 Jun; 267(6):353-7. PubMed ID: 4601711
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of urinary tract infections with cephalexin an oral antibiotic of cephalosporin-group].
    Hofmeister H; Scharrer G; Sawallisch R
    Arzneimittelforschung; 1970 Jan; 20(1):139-42. PubMed ID: 4986282
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM; Gebicka K; Borowski J
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacteriological and clinical evaluation of the combination of cloxacillin with ampicillin.
    Klastersky J; Debusscher L; Rühl D
    Chemotherapy; 1972; 17(6):382-91. PubMed ID: 4628324
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro action of carbenicillin against bacteria isolated from clinical material.
    Isenberg HD; Siegel M
    Appl Microbiol; 1969 Sep; 18(3):387-92. PubMed ID: 4392088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug susceptibility-resistance pattern of gram-negative uropathogens to seven cephalosporins.
    Seneca H
    Am J Med Sci; 1973 Nov; 266(5):381-5. PubMed ID: 4202701
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro antimicrobial activity and human pharmacology of cephaloglycin.
    Applestein JM; Crosby EB; Johnson WD; Kaye D
    Appl Microbiol; 1968 Jul; 16(7):1006-10. PubMed ID: 4385749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of BL-S217, a new cephalosporin antibiotic.
    Casey F; Bodey GP
    J Antibiot (Tokyo); 1974 Jul; 27(7):520-4. PubMed ID: 4156357
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro comparison of cefazolin with other cephalosporins.
    Yeivin R; Meshulam M; Sacks T
    Isr J Med Sci; 1974 Sep; 10(9):1092-5. PubMed ID: 4436031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.